Funding for this research was provided by:
National Natural Science Foundation of China (31872746, 81773620, 81573332)
National Key Basic Research Program of China (2015CB931800)
Shanghai Science and Technology Funds (18431902800)
Scientific Research Projects of Shanghai Municipal Commission of Health and Family Planning (201740140)
Text and Data Mining valid from 2019-12-01
Received: 3 March 2019
Accepted: 11 November 2019
First Online: 11 December 2019
Ethics approval and consent to participate
: Procedures involving BALB/c nude mice and C57BL/6 mice (six-week old, male) were performed in accordance with the standards of Fudan University and approved by Animal Ethical Committee of School of Pharmacy Fudan University.
: Not applicable.
: Song Li is the employee, and Wenzhi Tian is the founder of ImmuneOnco Biopharma (Shanghai) Co., Ltd. The other authors declare no conflict of interests.